Vasculogenic erectile dysfunction is a distinct clinical presentation of male erectile dysfunction in which cardiovascular risk factors play a central role. Effective management requires addressing both the dysfunction itself and the underlying vascular risk profile.
This protocol applies to men with vasculogenic erectile dysfunction — including those with mild vasculogenic ED, those who prefer to avoid or are not suitable for oral pharmacotherapy, and those who have responded poorly to first-line oral treatment.
Management begins with lifestyle modifications and correction of cardiovascular risk factors. A well-established class of oral pharmacotherapy is used as first-line treatment. For eligible patients, a physical energy-based therapy is an alternative or complementary option — including those who do not respond adequately to oral therapy.
Full regimen, agent selection, and sequencing available in the structured protocol →The target outcome is an erection with rigidity sufficient for satisfactory intercourse, with measurable improvement in validated erectile function scores. Clinical benefit is typically observed one to three months after treatment completion.